Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 325.80
+20.65 (6.77%)
Aug 21, 2026, 3:29 PM IST
Suraksha Diagnostic Revenue
Suraksha Diagnostic had revenue of 876.45M INR in the quarter ending June 30, 2026, with 20.75% growth. This brings the company's revenue in the last twelve months to 3.25B, up 23.31% year-over-year. In the fiscal year ending March 31, 2026, Suraksha Diagnostic had annual revenue of 3.10B with 23.13% growth.
Revenue (ttm)
3.25B
Revenue Growth
+23.31%
P/S Ratio
5.21
Revenue / Employee
2.50M
Employees
1,300
Market Cap
16.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.10B | 583.21M | 23.13% |
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Shalby | 11.76B |
| Windlas Biotech | 9.42B |
| Krsnaa Diagnostics | 8.41B |
| Tarsons Products | 4.41B |